M
icrobial colonisation occurs in virtually all acute, traumatic, surgical and chronic wounds.
1 Colonisation often involves potentially pathogenic organisms that can cause wound infec tion, delaying healing, 'traumatising' the patient and increasing treatment costs. Burns, diabetic foot ulcers, leg ulcers and pressure ulcers are particularly prone to complications from infection -for example, it is estimated that 75% of deaths following burn injuries are related to infection.
2 There is thus growing demand for effective wound management and therapeutic options to limit the risk of infection.
1
Practitioners and other decision-makers need to make rational choices between different supposedly antimicrobial dressings, but have little objective evidence on which to base them. These choices require an understanding of the complex underlying nature of wound infection, and the interaction between the wound, the microbial fl ora and the dressing.
Simple laboratory evaluations of the antimicrobial potency of dressings can be misleading, particularly with modern composite dressings, as the tests do not take account of this complex interaction. 3, 4 There is a need for in vitro laboratory tests that take into account at least the most basic aspects of this interplay, especially the way in which wound microbes are bathed in fl uid rich in organic, nutritional substances, most of which are drawn into the dressing 5 where they can inactivate antimicrobial agents.
Although systemic antibiotics are regarded as the ultimate treatment against wound infection, they are inappropriate in some cases, such as in burn injuries, 6 and can result in wound colonisation by resistant organisms.
7 Antiseptic skin-surface dressings, such as those containing iodine and silver, have long been used to control wound microfl ora and, in clinical practice, to combat infection. 8 The effi cacy of dressings in combating wound infection is variable. 9 Those that promote moist wound healing limit the spread of bacteria by aerosol formation on removal. 10 In vitro some can sequester and retain microorganisms, 11 reducing the microbial load in the wound and surrounding environment.
• Objective: To determine the antimicrobial activity and effi cacy of different formulations of novel bioxygenating hydrogel dressings (which deliver both iodine and oxygen into the wound) against various target organisms by means of an in vitro test system that more effectively mimics the conditions encountered when dressings are in contact with wounds.
• Method: Three bioxygenating hydrogels were tested: Oxyzyme, which releases low levels of iodine into the wound, and Iodozyme 402 and Iodozyme 401, which release higher levels of iodine, with Iodozyme 402 releasing twice the amount of 401. Cellulose fi lter disks (n=32) were inoculated with indicator species and placed equidistant from each other as a matrix onto agar test beds. Cut squares of control or test dressings were placed on top of each disk. Kill curves were constructed from determinations of the numbers of survivors (log cfu per disk) over time by removing disk samples at various time points.
• Results: Signifi cant differences (p<0.05) were observed between the controls and test samples. The order of sensitivity for Oxyzyme was Fusobacterium nucleatum, Bacteroides fragilis, Propionibacterium acnes, Staphylococcus epidermidis, methicillin-resistant Staphylococcus aureus (MRSA), Candida albicans and Pseudomonas aeruginosa. The order of effi cacy of the three hydrogel dressings (Iodozyme 402, followed by Iodozyme 401 and then Oxyzyme) was the same regardless of the target species.
• Conclusion: The novel hydrogel skin surface wound dressings are broad-spectrum in activity, encompassing antibiotic-resistant organisms, anaerobes and yeasts; their antimicrobial function appears to be rapidly effective.
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Although the use of antiseptics in wound care has long been debated, a recent wide-ranging review 12 concluded that 'antiseptics need not be omitted from the therapeutic armamentarium of wound care', quoting limited toxicity data, the broader antimicrobial spectrum and lower sensitisation rates. As antiseptics incorporated into wound dressings stay in contact with the wound for much longer than when in solution form, they can be more dilute, less toxic and exert a prolonged antimicrobial effect.
8
As wound-dressing technology becomes more advanced, new developments are emerging in which antimicrobial agents are delivered in a controlled manner from composite dressings that interact with the wound. For example, the prototype wound dressings Oxyzyme and Iodozyme (Insense, Bedford, UK) both utilise an enzyme (glucose oxidase) to help drive oxygen into the wound and synthesise a predetermined dose of iodine in the wound bed (Fig 1) . The integration of antiseptic iodine with oxygenation of the wound bed provides an effect we describe as wound 'bioxygenation'.
The steady release of iodine from both dressings exerts a gentle, surface antimicrobial effect at the interface between wound and dressing, which is ideal for wounds where the potential for infection must be considered. The level of iodine generated is determined by the concentrations of the enzyme and iodide in the dressing, as well as the pH, surfactant concentration and the dimensions of the gel layers. Iodozyme contains higher levels of iodide, and thus generates more iodine, than Oxyzyme. Iodozyme is thus designed for wounds with clinical signs of contamination; Oxyzyme is designed for clean wounds without obvious signs of contamination.
Currently, these biochemically active wound dressings are built into a hydrogel matrix consisting of three-dimensional networks of hydrophilic polymers that are fl exible, non-antigenic and capable of absorbing large amounts of wound fl uid; the dressings also provide a barrier to external infection. 13 A moist wound-healing environment is created by the occlusive nature of the hydrogel sheets and their ability to donate moisture. Both dressings are still in development and are not available commercially.
The antimicrobial activity of such composite, multi functional dressings cannot easily be evaluated by established in vitro methods as this would need to take account of their controlled mechanism of action and potential to interact with the wound. The key features of Oxyzyme and Iodozyme hydrogel systems that need to be considered are the:
• Mechanism and dynamics of iodine generation • Associated oxygen production • Steady take-up of wound-fl uid (which causes an associated swelling and dilution of the biochemical constituents).
Under aerobic, in vitro conditions it is diffi cult to measure the full impact of the oxygenation effect (which depends on the involvement of leucocytes), even though the oxygen-delivery mechanism will be active. However, the new test system enables the antimicrobial effi cacy of the gradual synthesis and release of iodine from the dressings to be determined. 2 Glucose in the wound contact layer is oxidised to form gluconic acid. This leads to the production of hydrogen peroxide, which is used to transport oxygen through the hydrogel layers 3 Within the hydrogel matrix, the hydrogen peroxide is consumed in a complex reaction pathway involving iodide ions, resulting in oxygen being released from the wound surface surface 4 Iodine is also generated in this reaction pathway, and is gradually released from the wound contact hydrogel matrix
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Moreover, it allows evaluation against anaerobes. The specifi c aim of this in vitro study was to determine the antimicrobial activity and effi cacy of three variants of this novel bioxygenating hydrogel system. However, the general approach can be used to compare and evaluate any dressing claimed to have antimicrobial effects. The general test system utilised here can therefore be used to help practitioners make rational decisions as to which active/advanced dressing to use in wound management, especially as it is important to objectively determine antimicrobial activity against a broad spectrum of target species, including methicillin-resistant Staphylococcus aureus (MRSA), anaerobes and yeasts. The effi cacy of dressings against anaerobes is often overlooked, despite the high correlation between the incidence of anaerobic bacteria and wound infection. 
Materials and method

Growth and maintenance of microorganisms
In this study a mixture of clinical and laboratorytyped strains were used to enable both comparisons with existing data for other novel antimicrobial dressings and determination of antimicrobial efficacy against clinically relevant pathogens.
Staphylococcus epidermidis (UWE laboratory typed strain isolated from human skin), MRSA Llewelyn clinical strain, Pseudomonas aeruginosa PAO 1161, Candida albicans NCTC 10288, Propionibacterium acnes (UWE laboratory typed strain isolated from human skin), Bacteroides fragilis ATCC 25285 and Fusobacterium nucleatum (subspecies nucleatum) ATCC 10953 were all maintained and stored as laboratory stocks.
Staphylococci and Pseudomonas aeruginosa were maintained on nutrient agar (Oxoid, Basingstoke, UK), Candida albicans on potato dextrose agar (Oxoid), and Propionibacterium acnes and the strict anaerobes on fastidious anaerobe agar (Oxoid) supplemented with 5% defi brinated horse blood (TCS Biosciences, Buckingham, UK).
Broth cultures of Staphylococcus epidermidis, MRSA, Pseudomonas aeruginosa, Candida albicans and Propionibacterium acnes were grown in 1% tryptone-0.5% yeast extract, and Bacteroides fragilis and Fusobacterium nucleatum in brain-heart infusion broth. At set times, the disks are removed and the numbers of surviving microbes quantifi ed by serial dilution and spiral plating
Test organisms are held within cellulose disks in close but indirect contact with the dressing under test, and are exposed to any antimicrobial effects for defi ned periods of time and under controlled physiochemical conditions. In addition, the organisms held in the disk are also infl uenced positively by the water and solutes in the nutrient agar, especially as they are drawn through the disks into the dressing by fl uid absorption. Quantifi able kill rates can then be accurately determined (previously described by Thorn et al.
)
The staphylococci Pseudomonas aeruginosa and Candida albicans were incubated at 37°C aerobically (Genlab M1005L incubator, Cheshire, UK), and Propionibacterium acnes and strict anaerobes were incubated at 37°C anaerobically (MK3 Anaerobic work station, Don Whitley Scientifi c, Shipley, UK). All cultures were subcultured weekly.
Experimental wound dressings
The wound dressings tested were prototype Oxyzyme and Iodozyme hydrogels.
The Oxyzyme hydrogel comprised a 100 x 100mm glucose plus iodide wound-contact layer and a 60 x 60mm enzyme surface layer. The latter is responsible for the hydrogen peroxide-driven oxygen transport and iodine generation from the wound-contact layer (Fig 1) .
The essentially similar Iodozyme hydrogels were supplied at two iodide concentrations (test hydrogels 401 and 402), again comprising a 100 x 100mm glucose plus iodide wound-contact layer but with a 100 x 100mm enzyme surface layer. These generated and released higher concentrations of iodine. The concentration of iodide in hydrogel 402 was twice that of hydrogel 401.
All wound dressings were supplied in their standard packaging, and cut into 16 sections of required size just before use.
Controls
The control wound dressing (control 1) comprised only the glucose plus iodide wound-contact layer and not the surface enzyme layer, thus preventing hydrogen peroxide and iodine generation (Fig 2) .
Uncovered disks (n=16) were also placed onto the test plates containing equivalent numbers of target species as an additional control (control 2).
Disk inoculation
Test cell suspensions were prepared from neat 24-hour broth cultures of Staphylococci and Pseudomonas aeruginosa, 48-hour broth cultures of Candida albicans and 72-hour broth cultures of Propionibacterium acnes and strict anaerobes, diluted if necessary with sterile broth to give optical density readings of 0.5-0.7 using a 1cm light path CE-373 linear readout grating spectrophotometer (Cecil Instruments, Cambridge, UK) at wavelength 540nm.
Ultraviolet-sterilised 1cm 2 cellulose disks (n=32) were then immersed in vortex-mixed test-cell suspensions for fi ve minutes and placed into a sterile plastic Petri dish; excess fl uid was removed from each disk by sterile blotting. All disks then contained approximately the same numbers of viable cells.
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Test method
The test method used was that described previously by Thorn et al. 14 (Fig 2) . Briefl y, the test and control 1 wound dressings (n=16, 25 x 25mm) were evenly distributed onto the surface of 10mm-thick 1% weight per volume (w/v) agar in 1% w/v tryptone-0.5% w/v yeast-extract agar within a large square assay plate.
Sample positions were determined by reference to a grid matrix (intersection of rows and columns), and the sequence of samples was determined according to Latin square principles.
The test plates were preincubated for two hours (to equilibrate) prior to the introduction of the test disks containing equivalent numbers of target species. These were placed between the agar layer and the test and control dressings using sterile forceps.
Small metal weights (12g) on nylon mesh pads were applied to the top surface of each hydrogel square to maintain contact between the hydrogel, cellulose disk and agar surface during incubation.
All assay plates were incubated at 25°C for the duration of the experiments. Sample disks were removed at appropriate times (determined from preliminary experiments to roughly estimate kill rates) and the number of survivors was determined by viable count as previously described.
14
Analysis of results
For each test species and each condition, plots were made of log numbers of survivors over reaction time, and kill rates determined by linear regression, enabling direct comparison of the results over time for the test and two controls for each target species.
Graph construction, statistical analyses and modelling were conducted using GraphPad Prism version 3.02 for Windows (GraphPad Software, San Diego, USA). Analysis of covariance (ANCOVA) was used to ascertain whether there was a signifi cant difference between rates. A p value of <0.05 was regarded as signifi cant. In order to take into account any 
Results
Both Oxyzyme and Iodozyme test dressings exhibited a signifi cant anti micro bial effect against all test organisms. Plotting log numbers of survivors over the reaction time enabled the determination of kill rates. Those for Oxyzyme are given in Table 1 . To compare with other species and conditions, an average kill rate value was estimated between the maximum and minimal rates of the acceleration. All test kill rates were signifi cantly different (p<0.0001) to no change (fl at line) or either of the two corresponding control conditions, and to each other.
The death kinetics for Staphylococcus epidermidis 14 and MRSA treated with Oxyzyme exhibited an accelerating kill rate. When Oxyzyme was tested against Pseudomonas aeruginosa there was a signifi cant antimicrobial effect for the fi rst 6½ hours of treatment. After this period signifi cant regrowth occurred, eventually reaching levels close to that of both controls, even though both sets of control samples exhibited signifi cant growth rates. No such regrowth was seen during treatment with the Iodozyme hydrogels. Signifi cant growth on the control samples (control 2) was observed for Candida albicans. However, all test hydrogels exhibited a signifi cant kill rate throughout the treatment duration for Candida.
For all anaerobes (Propionibacterium acnes, Bacteroides fragilis and Fusobacterium nucleatum) treated with the Oxyzyme hydrogel, signifi cant kill rates were observed for both test and control samples. However, test conditions (in the presence of active hydrogels) gave the highest kill rates and were signifi cantly different to the control kill rates (p<0.0001).
Using the formula stated in the methodology 15 a comparative graph of Oxyzyme kill rates for all target species was constructed (Fig 3) . This method takes into account and corrects for any population changes that occur within the control samples. All kill rates were signifi cantly different from each other (p<0.0001). Hence, the order of sensitivity to the test Oxyzyme hydrogel was:
Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans were treated with all three hydrogel wound dressing formulations (Oxyzyme, Iodozyme 401 and Iodozyme 402). All wound dressings gave kill rates signifi cantly different (p<0.0001) to no change (fl at line) or either of the two control research conditions, and all kill rates were signifi cantly different from each other (p<0.0001).
The order of effi cacy of the hydrogel dressings was the same regardless of target species: Iodozyme 402, followed by Iodozyme 401, and then Oxyzyme.
Discussion
These fi ndings point the way to the further development of a realistic in vitro wound-bed model, and will help to refi ne the mode of use and optimisation of the wound dressings themselves.
It should be noted that the low-iodine Oxyzyme hydrogel is mainly intended as a prophylactic to minimise the risk of infection; the higher-iodine Iodozyme variants are designed for infected wounds. Although all test dressings exerted a signifi cant antimicrobial effect against all target species, they did so, as expected, with different potency.
Oxyzyme hydrogel was most effective against the strict anaerobes Bacteroides fragilis and Fusobacterium nucleatum, followed by the aerotolerant anaerobe Propionibacterium acnes.
As might be expected with anaerobes, aerobic conditions alone (controls 1 and 2) produced a killing effect. However, in all cases these rates were considerably less than those induced by the active test dressing, so the difference between the control and test rates can be ascribed to the antimicrobial efficacy of the dressing.
Control 1 (glucose plus iodide wound-contact layer without the surface enzyme layer) produced a higher kill rate than control 2, possibly because the inactive iodide in the test dressing was slowly oxidised by redox activity of the test microbial cells, yielding traces of iodine.
The marked effi cacy of Oxyzyme against anaerobes is of particular clinical signifi cance in the light of increasing clinical publications correlating prevalence of anaerobic bacteria with wound infection.
1
Oxyzyme was signifi cantly effective against Staphylococcus epidermidis and MRSA, which is important in view of the emergence of antibiotic-resistant organisms, particularly MRSA, within wounds. This has heightened the need for an effective prophylactic that can reduce the colonisation and/or the bacterial load of wounds by antibiotic-resistant organisms.
Although fungal infections of skin wounds are less common than those associated with bacteria, 16 the increase in antifungal resistance shown by Candida albicans 17 makes this an interesting target species to test against Oxyzyme. The killing of the eukaryotic Candida albicans was less effective than that measured against the prokaryotic anaerobes and Staphylococci, although it was still signifi cant. The more resistant nature of Candida albicans (compared with Staphylococci) has also been observed previously in photodynamic killing using methylene blue and light.
18
The lower effi cacy of Oxyzyme against Pseudomonas aeruginosa, with regrowth after a killing phase of 6½ hours, is consistent with the known robustness of this organism. Pseudomonas aeruginosa is a persistent and versatile opportunistic pathogen that can adapt to and utilise numerous environmental conditions -a capability that strengthens its pathogenic potential in wounds (particularly burns) often associated with transmissible virulence factors.
19
Although Oxyzyme had limited antimicrobial effi cacy against Pseudomonas aeruginosa, both Iodozyme hydrogels (401 and 402) exerted significant and prolonged antimicrobial activity, with no regrowth. This suggests the increased generation of iodine within these two hydrogel dressings increases their antimicrobial power.
This association between increased iodine generation capacity and antimicrobial power was also evident in the experiments with the Iodozyme hydrogels and Staphylococcus epidermidis 14 and Candida albicans. In all cases a signifi cant difference was seen between all three hydrogel dressings, with increasing antimicrobial power relating to iodide content.
Conclusion
Many skin-surface dressings incorporate antiseptics including iodine, chlorhexidine or silver compounds. Oxyzyme and Iodozyme hydro gels use antimicrobial systems that integrate active oxygenation with controlled synthesis and release of iodine. The correction of wound hypoxia by delivery of oxygen promotes natural antimicrobial effects (especially via enhanced leucocyte activity) and biochemical healing processes, all within a moist wound environment, resulting in many antimicrobial effects.
In view of the demonstrated effective antimicrobial properties of these novel hydrogel dressings, their use in the clinical environment could be signifi cant in reducing the microbial load of a wound, thereby limiting or inhibiting infection. They are broad-spectrum in activity, including antibioticresistant organisms, anaerobes and yeasts, and were found to be rapidly effective. These dressings could signifi cantly enhance the treatment of wounds prone to complications of infection. This offers potential benefi ts to the patient through decreased trauma, and could signifi cantly reduce treatment costs.
There are limitations with the in vitro model used in that the host response is not taken into account, and so will not determine wound events or healing but merely the propensity of the dressings to kill potentially pathogenic wound-infecting microbes.
Further testing is needed to determine the effectiveness of the dressings in limiting colonisation of potentially pathogenic organisms in the wound environment in vivo. Further developments of the in vitro model will be undertaken, especially as a means through which to optimise dressing performance. ■
